Diabetes

The Effects of White Potatoes vs White Rice on Type 2 Diabetes

September 16th 2025

Data reveal a growing burden of early-onset type 2 diabetes, highlighting disparities and increased cardiometabolic risk

Carbohydrates | Image credit: EMB DESIGNER - stock.adobe.com

GLP-1 RAs Linked to BMI-Dependent Heart Benefits in Type 2 Diabetes

September 10th 2025

BMI obesity - Vitalii Vodolazskyi - AdobeStock_109782881.jpeg

Mobile Text Messages Improve Diabetes, Heart Risk Control

September 8th 2025

Woman laying on bed with mobile phone, using medical app | Prostock-studio - stock.adobe.com

Global Gaps in Diabetes Technology, Insulin Linked to Poor Outcomes

September 2nd 2025

1 Credit / Cardiology, Neurology

August 27th 2025

Advancing Care in Type 2 Diabetes and Obesity: A Coordinated, Guideline-Driven Approach

Understand how recent advances in GLP-1 receptor agonists and other therapies are transforming the treatment of type 2 diabetes and obesity through a shift of reactive to proactive care that addresses root causes of cardiometabolic disease.

Watch Now

Continuing Medical Education

View All

September 18th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

September 18th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

September 30th 2015

Conflict of Interest Rampant in Academic-Industry Partnerships

A study published in BMJ measured the prevalence, annual compensation, and beneficial stock ownership of directors from publicly traded healthcare companies who had academic affiliations.

September 30th 2015

A Randomized Controlled Trial of Negative Co-Payments: The CHORD Trial

Kevin G. Volpp, MD, PhD Andrea B. Troxel, ScD Judith A. Long, MD Said A. Ibrahim, MD, MPH Dina Appleby, MS J. Otis Smith, EdD Jalpa A. Doshi, PhD Jane Jaskowiak, BSN, RN Marie Helweg-Larsen, PhD Stephen E. Kimmel, MD, MSCE

This study extends value-based insurance design concepts in testing the impact on blood pressure control of rewards that provided negative co-payments for blood pressure medication.

September 30th 2015

A Randomized Controlled Trial of Co-Payment Elimination: The CHORD Trial

Kevin G. Volpp, MD, PhD Andrea B. Troxel, ScD Judith A. Long, MD Said A. Ibrahim, MD, MPH Dina Appleby, MS J. Otis Smith, EdD Jane Jaskowiak, BSN, RN Marie Helweg-Larsen, PhD Jalpa A. Doshi, PhD Stephen E. Kimmel, MD, MSCE

This study tests the impact on blood pressure control of a reward that lowered co-payments for blood pressure medication to $0.

September 29th 2015

Lixisenatide New Drug Application Accepted for Review With CV Results Already in Hand

Results presented at the American Diabetes Association in June showed no CV risk or benefit and no risk of pancreatic injury, an issue that has been of particular concern to FDA.

September 28th 2015

Behavioral Health at Heart of Recommended Medicaid Measures From National Quality Forum

The recommendations for improving quality care in Medicaid track recent trends in psychiatric and diabetes care, which recognize the connection between physical and mental health.

September 28th 2015

Medtronic Announces US Availability of MiniMed Connect Technology

The technology was approved by FDA in June and unveiled at the Scientific Sessions of the American Diabetes Association.

September 28th 2015

Diabetes: The Next Healthcare Tsunami

Brenda Schmidt

Eighty-six million US adults are at high risk of developing type 2 diabetes. Without prevention, there will be a drastic increase in the number of Americans who will develop type 2 diabetes.

September 25th 2015

Dexcom G5 Mobile CGM System Approved by FDA

Synjardy Joins Ranks of Combo Therapies for T2DM

September 25th 2015

Outlook Changing in Payer Coverage for Obesity Medications, Commentators Say

September 25th 2015

Many hoped the 2013 declaration by the American Medical Association that obesity is a disease would open the door for payer coverage of pharmacotherapy to treat it. While that did not happen right way, a new commentary in Evidence-Based Diabetes Management by Ted Kyle, RPh, MBA, and Fatima Cody Stanford, MD, MPH, MPA, outlines how the tide appears to be turning for coverage of evidence-based treatment.

September 25th 2015

Joslin Diabetes Center Taps Amenta as New President & CEO

Peter S. Amenta, MD, PhD, spent 8 years as the dean of Rutgers Robert Wood Johnson Medical School during a period of tremendous growth and change.

September 24th 2015

Empagliflozin Is First Diabetes Drug to Hit "Holy Grail" of Cutting Heart Attack, Stroke Deaths in Clinical Trial

Blood Pressure Medication at Night Lowers Diabetes Risk, Studies Say

September 24th 2015

The research by the group from Spain is the latest effort to link sleep patterns, or disruption of sleep, to the development of type 2 diabetes.

September 23rd 2015

Fingernail Tests May Offer Cheap, Simple Way to Diagnose Diabetes

Fingernail tests could offer a solution to diabetes testing in the developing world, and a faster test for gestational diabetes could diagnose this condition earlier in pregnancy.

September 23rd 2015

Dissecting the Patient Perception of FDA's Breakthrough Designation

A JAMA Internal Medicine study found the terms "breakthrough" and "promising" raised people's expectations on the drug's performance as opposed to when the drugs were described as having met the breakthrough criteria.

September 23rd 2015

Survey Finds Young Patients With Diabetes Getting Fewer Eye Exams Than Older Patients

Younger patients and those newly diagnosed were more likely to not receive eye exams than older persons with diabetes.

September 23rd 2015

Type 2 Diabetes Patients Should Be Screened for Liver Disease, Study Suggests

Screening in a primary care setting may help managed care plans avoid long-term costs of complications of type 2 diabetes.

September 23rd 2015

Clinton Seeks Cap on Drug Expenses, Would Let Medicare Negotiate

Hillary Clinton unveiled a plan in Iowa that features a $250 per month cap on drug costs for patients with chronic conditions. This comes 2 weeks after her chief rival for the Democratic nomination, US Senator Bernie Sanders of Vermont, introduced a bill aimed at reining in drug costs. In the summer, The American Journal of Managed Care said polling showed that rising drug costs were poised to become a major issue in the 2016 campaign.

September 23rd 2015

Physicians Believe in Biosimilars but Lack Awareness, Says Report by Quantia

A white paper released by QuantiaMD has identified a lack of awareness and education about biosimilars among prescribing physicians.

September 22nd 2015

Intarcia Says Phase 3 Results Show Better Control Than Januvia for Type 2 Diabetes Mellitus

The matchstick-like delivery system has been seen as game-changer in overcoming poor adherence. Filing for FDA approval is anticipated in early 2016.

September 22nd 2015

JAMA: High-Dose Liraglutide Causes Significant Weight Loss in Overweight Persons With T2DM

The study showed an average weight loss of 6%, and weight loss of 10% for a quarter of the patients. Average BMI was 37.

September 22nd 2015

Research Describes "Dimmer Switch" in Pancreatic Islet Cells

AJMC Staff

The research could hold the key to a novel treatment for type 2 diabetes, although it will take years to adapt the idea to clinical practice.

September 21st 2015

Does Passive Smoking Boost Diabetes Risk? A Lancet Meta-analysis Says Yes

Researcher found that not only was passive smoking associated with increased risk of type 2 diabete, but there was a direct dose-response relationship.

September 21st 2015

New FDA Nominee May Face Challenges for His Pharma Ties

A report in The New York Times identifies challenges that could be raised based on Califf's past associations with the drug industry.

September 21st 2015

Dr Andrew Pumerantz Reflects on the Role of Primary Care in Diabetes

Although primary care is important, it may not be the center of the care model for patients with chronic diseases, like type 2 diabetes, and these providers are usually just a part of a larger ecosystem of providers, said Andrew Pumerantz, DO, FACP.

September 19th 2015

Integrating Community, Clinical Services to Prevent and Treat Obesity

Laura Joszt, MA

Researchers are proposing a new model to integrate clinical and community services for the purpose of preventing and controlling obesity, as well as related chronic diseases, such as type 2 diabetes.

September 18th 2015

Stumbling Toward Access to Evidence-Based Care for the Chronic Disease of Obesity

Theodore K. Kyle, RPh, MBA Fatima Cody Stanford, MD, MPH, MPA

Many hoped the 2013 declaration by the American Medical Association that obesity is a disease would open the door to improved coverage for pharmcotherapy. That did not happen right away, but signs of change are emerging.

September 18th 2015

Joslin's Hamdy: Evidence Shows Diet, Exercise Effective Against Diabetes, Obesity Long-Term

Andrew Smith

A 5-year study reveals that the properly constructed diet, along with exercise aimed at muscle maintenance, can achieve long-term weight loss results.

September 18th 2015

"Artificial Pancreas" System Performs Well in Home-Based Trial, Researchers Report

Patients whose blood sugar and insulin delivery was managed by software had been control than those who had to self-monitor their insulin delivery.

September 18th 2015

NIH Approves Blueprint for Obama's Precision Medicine Initiative